We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Arcus Biosciences

News List

Arcus Biosciences and WuXi Biologics expand deal for antibodies development pharmaceutical-technology
December 11, 2020
Biopharmaceutical company Arcus Biosciences has expanded its existing strategic relationship with Chinese company WuXi Biologics to discover anti-CD39 antibodies using the latter’s proprietary technology.
Gilead and Arcus Biosciences partner to develop cancer drugs pharmaceutical-technology
May 29, 2020
Gilead Sciences has partnered with Arcus Biosciences to jointly develop and commercialise current and future cancer therapeutic candidates in the latter’s pipeline.
Ligand to receive US$2mn from WuXi Biologics for licensing antibody pharmaasia
August 23, 2017
Ligand is also entitled to future milestones and royalties from this antibody.